Hyperspectral Imaging, OCT Team to Detect Early Biomarkers of Alzheimer’s Disease - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Hyperspectral Imaging, OCT Team to Detect Early Biomarkers of Alzheimer’s Disease

    Article obtained from Photonics RSS Feed.

    A team of scientists and engineers from Katholieke Universiteit (KU) Leuven, Universitair Ziekenhuis (UZ) Leuven, and the research organization VITO, collaborating with the international research and development group imec, used imec’s hyperspectral snapshot camera, SNAPSCAN, to collect information from 16 spectral bands (460 to 620 nm, 10-nm bandwidth) in a single capture. The potential for retinal imaging to serve as a tool for the early diagnosis of Alzheimer’s disease is the focus of the team’s research, which is specifically exploring retinal imaging techniques to quantify the accumulation of amyloid-beta protein in the brain.

    Using SNAPSCAN, the team combined hyperspectral retinal imaging and OCT to…

    READ MORE
    Jun, 02 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.